|
|
||||||||
J Thorac Cardiovasc Surg 1997;114:497-499
© 1997 Mosby, Inc.
BRIEF COMMUNICATIONS |
New York, N.Y., and Stanford, Calif.
Received for publication Dec. 24, 1996; accepted for publication Jan. 3, 1997. Address for reprints: Daniel Burkhoff, MD, PhD, Department of Medicine, Columbia University, 630 W. 168th St., New York, NY 10032.
Transmyocardial laser revascularization (TMLR) is currently being actively investigated as a therapy for patients with medically refractory angina who cannot be treated by either coronary bypass grafting or percutaneous transluminal coronary angioplasty.
1 The original idea behind TMLR was to mimic the physiology of myocardial perfusion in reptile hearts by creating channels for blood to flow from the ventricular chamber to directly perfuse the myocardium. However, with elucidation of the anatomic features of alligator hearts, which permit a substantial amount of direct myocardial perfusion to occur,
2 it has become unclear whether creation of channels that are 1 mm in diameter and 1cm apart can provide perfusion to a substantial amount of myocardium. Results of experiments performed in animals have raised other questions about the physiology of TMLR channels; thus far, no direct evidence has been found to indicate that blood flow through transmyocardial laser channels contributes to myocardial perfusion in mammalian hearts. In this case report we present histologic images that demonstrate naturally occurring subendocardial myocardial channels in a patient with severe coronary artery disease. These unique images reveal a pattern of myocardial viability around the natural channels. The images suggest that direct myocardial perfusion from the chamber is possible but, as for alligator hearts, that a very high channel density would be required to achieve a physiologically meaningful degree of myocardial perfusion. In addition, this patient underwent TMLR with a holmium:yttrium-aluminum-garnet (YAG) laser 2 weeks before his death, and we provide the first reported histologic studies of permanent holmium: YAG channels in human myocardium.
The patient was a 74-year-old man with multiple cardiac risk factors, a remote myocardial infarction, and fourvessel coronary bypass grafting 10 years before his death. Symptoms of heart failure and angina recurred 3 years after the operation. Despite maximal tolerable medical therapy, these symptoms had worsened significantly during the past year. Cardiac catheterization revealed significant left main stenosis and occlusion of the native circumflex, right coronary, and mid-left anterior descending (LAD) arteries; saphenous vein grafts were occluded, but a left internal thoracic artery graft to the LAD was patent. Echocardiography showed the ejection fraction to be about 40%. He was deemed to be an unsuitable surgical candidate and continued to receive medical therapy. Because of continued worsening of symptoms and the lack of other options, he was referred for treatment with TMLR using a holmium: YAG laser (Cardio Genesis Corp., Sunnyvale, Calif.). After consenting to participate in the investigation, he underwent the procedure during which time 24 channels were created with about 1 cm interchannel spacing in the inferoapical and lateral left ventricular walls. The postoperative course was unremarkable and he was discharged on postoperative day 4. On postoperative day 13 the patient noted worsening shortness of breath. He died in his sleep the next morning.
Autopsy revealed extensive coronary artery disease with 80% stenosis of the proximal left main coronary artery, complete occlusion of the LAD distal to the internal thoracic artery anastomosis, and complete occlusion of the proximal circumflex and right coronary arteries. Approximately 24 granulating epicardial scars, each less than 3 mm in diameter, were identified in the region in which the TMLR was performed. An acute and organizing subendocardial myocardial infarction measuring 8 x 6 cm was present in the posterior left ventricular free wall and interventricular septum. The findings of neutrophils, myocardial necrosis, and granulation tissue with early fibrosis were consistent with 3-to 14-day-old infarcts in this region. The timing of the LAD occlusion could not be determined from this evaluation.
Fig. 1 shows the typical appearance of TMLR-treated myocardium 2 weeks after surgery. The central core of the channel is filled with organized thrombus surrounded by granulation tissue with associated vascularity, comprising what we have referred to as a a channel remnant. The overall appearance of these channel remnants, which we believe are the first published images of subacute holmium:YAG TMLR channels, were similar to what we have seen in a human autopsy specimen from another patient after TMLR treatment with a carbon dioxide laser
3 and in dog hearts with both holmium:YAG and carbon dioxide lasers.*
|
|
8 cells thick) with relatively short myocardial distances from the channel edges and high surface area for nutrient and waste exchange.
As observed in this patient and in the experimental setting,* the appearance of TMLR channels 2 weeks after surgery (i.e., channel remnants) is very different from that of both alligator heart channels and the naturally occurring sinusoids described herein. This strikingly different appearance of channel remnants suggests that mechanisms other than direct myocardial perfusion by blood flowing through truly patent permanent channels may underlie the clinical benefits of TMLR. Further evidence for lack of substantial direct myocardial perfusion in the subacute setting is provided by the fact that, as in this patient, TMLR channels fail to protect myocardium from postoperative myocardial infarction. Myocardial infarction is emerging as the major cause of postoperative morbidity and mortality after TMLR. On the other hand, results of two independent clinical studies with a carbon dioxide laser have documented an increase in regional blood flow by 3 months after the therapy.
1,4 Consistent with these clinical studies, results of recent studies in animals suggest that one possible contributing mechanism may relate to stimulation of vascular growth after myocardial laser treatment.
5 These findings, coupled with the observed average two-class reduction in angina at 3 months, which improves further over the course of the first postoperative year, suggests that this therapy provides benefits that cannot be explained by either placebo or thoracotomy effects. These types of encouraging results will continue to fuel a great deal of interest in a thorough evaluation of the clinical efficacy and search for the mechanisms underlying TMLR.
Footnotes
From the Department of Medicine,a Columbia University, New York, N.Y., and the Departments of Pathologyb and Cardiothoracic Surgery,c Stanford University, Stanford, Calif. ![]()
*Fisher PE, Kohmoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial laser channels: comparison of acute and chronic effects of different lasers. Unpublished data. ![]()
*Fisher PE, Kohmoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial laser channels: comparison of acute and chronic effects of different laser. Unpublished data. ![]()
*Fisher PE, Kohmoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial laser channels: comparison of acute and chronic effects of different lasers. Unpublished data. ![]()
References
This article has been cited by other articles:
![]() |
J. Tasse and R. Arora Transmyocardial Revascularization: Peril and Potential Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 44 - 53. [Abstract] [PDF] |
||||
![]() |
L. Y. Lee, M. F. O'Hara, E. B. Finnin, R. Hachamovitch, M. Szulc, P. D. Kligfield, P. M. Okin, O. W. Isom, and T. K. Rosengart Transmyocardial laser revascularization with excimer laser: clinical results at 1 year Ann. Thorac. Surg., August 1, 2000; 70(2): 498 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Whittaker Transmyocardial revascularization: the fate of myocardial channels Ann. Thorac. Surg., December 1, 1999; 68(6): 2376 - 2382. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |